Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
May 2023 Novo Nordisk pauses key Wegovy promotional efforts and limits supply of starter doses as a response to growing demand
Overestimation of risk : Programs may overestimate the risk in individuals experiencing lower mortality due to these treatments, leading to less competitive offers and a potential worsening of the metabolic risk pool
Sign in or create one at checkout
Cardio vs
To meet demand, both Lilly and Novo look to expand supply capacity of their GLP-1 portfolios
US$ 22.38
US$ 28.78
US$ 22.93
US$ 21.78
US$ 20.86
US$ 28.61
US$ 25.98
US$ 28.58
US$ 25.63
US$ 22.46
US$ 26.71
US$ 22.04
US$ 23.74
